Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

7/27/22 7:29:48 AM ET

Retail-Auto Dealers and Gas Stations

Consumer Discretionary

Semiconductors

Technology

Get the next $CVNA alert in real time by email

Pzena Investment Management, Inc (NYSE:PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise quarterly sales.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) rose 18.3% to $8.42 in pre-market trading after the company reported better-than-expected financial results.
Western Midstream Partners, LP (NYSE:WES) rose 11.1% to $29.46 in pre-market trading. Western Midstream Partners recently announced that the board of directors of its general partner declared a quarterly cash distribution of $0.50 per unit for the second quarter.
Enphase Energy, Inc. (NASDAQ:ENPH) shares rose 9.9% to $237.50 in pre-market trading after the company reported better-than-expected Q2 EPS and sales results and issued Q3 revenue guidance above analyst estimates.
eXp World Holdings, Inc. (NASDAQ:EXPI) rose 6.6% to $14.50 in pre-market trading. eXp World Holdings is expected to announce Q2 results on August 3, 2022.
Carvana Co (NYSE:CVNA) rose 6.3% to $25.70 in pre-market trading. Raymond James upgraded Carvana from Underperform to Market Perform.
PayPal Holdings, Inc. (NASDAQ:PYPL) rose 5.7% to $81.44 in pre-market trading. Activist investor Elliott Investment Management has taken a stake in PayPal Holdings Inc, Bloomberg News reported.
SolarEdge Technologies, Inc. (NASDAQ:SEDG) rose 5.6% to $313.00 in pre-market trading. JP Morgan recently maintained an Overweight rating on the stock and raised its price target from $382 to $396.
Microsoft Corporation (NASDAQ:MSFT) rose 3.7% to $261.20 in pre-market trading. Microsoft reported weaker-than-expected results for its fourth quarter on Tuesday. However, the company issued an upbeat sales outlook for the fiscal year.
Alphabet Inc. (NASDAQ:GOOGL) rose 3.5% to $108.68 in pre-market trading. Alphabet reported downbeat earnings for its second quarter on Tuesday. However, revenue for the company’s Search and Other segment was $40.7 billion, up 13.7% year-over-year.

Also check this out: U.S. Stock Futures Gain; All Eyes On Fed Decision .

Get the next $CVNA alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$CVNA
$ENPH
$EXPI
$GOOGL

Company	Date	Price Target	Rating	Analyst
SolarEdge Technologies Inc. $SEDG	2/19/2026	$38.00 → $43.00	Buy	TD Cowen
PayPal Holdings Inc. $PYPL	2/10/2026	$58.00 → $39.00	Sell	Truist
Microsoft Corporation $MSFT	2/9/2026		Buy → Hold	Melius
Microsoft Corporation $MSFT	2/5/2026	$392.00	Buy → Hold	Stifel
Enphase Energy Inc. $ENPH	2/4/2026	$52.00	Hold → Buy	HSBC Securities
PayPal Holdings Inc. $PYPL	2/4/2026		Mkt Outperform → Mkt Perform	Citizens JMP
PayPal Holdings Inc. $PYPL	2/4/2026	$47.00	Buy → Hold	HSBC Securities
PayPal Holdings Inc. $PYPL	2/4/2026	$42.00	Buy → Hold	Canaccord Genuity

More analyst ratings

$CVNA
$ENPH
$EXPI
$GOOGL
Press Releases

Fastest customizable press release news feed in the world

U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by addressing the lack of viable long-acting olanzapine formulations1Teva is committed to advancing this innovative treatment option and further building on its differentiated LAI franchise and scientific leadership in complex neurological conditions as it drives forward its Pivot to Growth strategy PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of

2/20/26 2:43:11 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

ModelFront Announces General Availability of Automatic Post-Editing

Additional LLM to grow automation now included by default for all customers. ModelFront today announced the general availability of automatic post-editing (APE), an additional private custom large language model. First rolled out in 2024, APE is now rolled out to all ModelFront customers in production and included by default from day one. ModelFront's quality prediction (QP) is AI to check and fix AI translations. It automatically verifies segments that humans would verify unedited, and triggers human intervention for those that need it. Enterprise translation buyers use QP to automate and scale while keeping human quality. While QP alone successfully automated segments that profess

2/19/26 8:57:00 AM ET

Investment Managers

Finance

Catalog/Specialty Distribution

Consumer Discretionary

Western Midstream Announces Record Fourth-Quarter and Full-Year 2025 Results

Announces 2026 Financial GuidanceReported fourth-quarter 2025 Net income attributable to limited partners of $187.2 million, generating record fourth-quarter Adjusted EBITDA(1) of $635.6 million, which included $29.5 million of unfavorable non-cash revenue adjustments.Reported full-year 2025 Net income attributable to limited partners of $1.154 billion, generating record full-year Adjusted EBITDA(1) of $2.481 billion, exceeding the midpoint of the full-year 2025 Adjusted EBITDA guidance range of $2.350 billion to $2.550 billion, and representing a 6-percent year-over-year increase.Reported fourth-quarter 2025 Cash flows provided by operating activities of $557.6 million, generating fourth-qu

2/18/26 4:05:00 PM ET

Natural Gas Distribution

Utilities

$CVNA
$ENPH
$EXPI
$GOOGL
Financials

Live finance-specific insights

Western Midstream Announces Record Fourth-Quarter and Full-Year 2025 Results

Announces 2026 Financial GuidanceReported fourth-quarter 2025 Net income attributable to limited partners of $187.2 million, generating record fourth-quarter Adjusted EBITDA(1) of $635.6 million, which included $29.5 million of unfavorable non-cash revenue adjustments.Reported full-year 2025 Net income attributable to limited partners of $1.154 billion, generating record full-year Adjusted EBITDA(1) of $2.481 billion, exceeding the midpoint of the full-year 2025 Adjusted EBITDA guidance range of $2.350 billion to $2.550 billion, and representing a 6-percent year-over-year increase.Reported fourth-quarter 2025 Cash flows provided by operating activities of $557.6 million, generating fourth-qu

2/18/26 4:05:00 PM ET

Natural Gas Distribution

Utilities

Carvana Announces Record Fourth Quarter and Full Year 2025 Results

Record Full Year Retail Units Sold of 596,641, up 43% YoY Record Full Year Revenue of $20.3 billion, up 49% YoY Record Full Year Net Income of $1.9 billion1, up more than $1 billion YoY Record Full Year Adjusted EBITDA of $2.2 billion, up more than $850 million YoY Expects Significant Growth in Retail Units Sold and Adjusted EBITDA2 in FY 2026 and Sequential Increase in Retail Units Sold and Adjusted EBITDA2 in Q1 Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced financial results for the full year and quarter ended December 31, 2025. Carvana's complete fourth quarter and fiscal year 2025 financial results and management commentary are

2/18/26 4:05:00 PM ET

Retail-Auto Dealers and Gas Stations

Consumer Discretionary

SolarEdge Announces Fourth Quarter and Full Year 2025 Financial Results

SolarEdge Technologies, Inc. (NASDAQ:SEDG), a global leader in smart energy technology, today announced its financial results for the fourth quarter and year ended December 31, 2025. "Our fourth quarter results delivered 70% year-over-year revenue growth, marking our fourth consecutive quarter of year-over-year revenue growth and fifth consecutive quarter of margin expansion," said Shuki Nir, CEO of SolarEdge. "In 2025 we restored discipline, generated strong free cash flow, and rebuilt margins. In 2026 we are shifting decisively to offense, focused on moving toward profitable growth and capturing global market share through the rollout of the SolarEdge Nexis platform. By leveraging our D

2/18/26 7:30:00 AM ET

Semiconductors

Technology